Promises and Challenges of Cell-Based Therapies to Promote Lung Regeneration in Idiopathic Pulmonary Fibrosis

• Published in: Cells (Basel, Switzerland) Vol. 11; no. 16; p. 2595
• Main Authors: Egea-Zorrilla, Alejandro, Vera, Laura, Saez, Borja, Pardo-Saganta, Ana
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.08.2022; MDPI
• Subjects: alveolar epithelial cells; Alveoli; Care and treatment; cell therapy; Cellular therapy; Clinical trials; Disease; Epithelial cells; Epithelium; Etiology; Extracellular matrix; Fibroblasts; Fibrosis; Health aspects; Lung diseases; lung regeneration; Lungs; Methods; Pathogenesis; Physiology; Progenitor cells; Pulmonary fibrosis; Recovery of function; Regeneration (Biology); Respiratory function; Review; Stem cells; stem/progenitor cells; Surfactants; tissue homeostasis; Transplantation; Transplants & implants; Wound healing; Germany
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells11162595

The lung epithelium is constantly exposed to harmful agents present in the air that we breathe making it highly susceptible to damage. However, in instances of injury to the lung, it exhibits a remarkable capacity to regenerate injured tissue thanks to the presence of distinct stem and progenitor cell populations along the airway and alveolar epithelium. Mechanisms of repair are affected in chronic lung diseases such as idiopathic pulmonary fibrosis (IPF), a progressive life-threatening disorder characterized by the loss of alveolar structures, wherein excessive deposition of extracellular matrix components cause the distortion of tissue architecture that limits lung function and impairs tissue repair. Here, we review the most recent findings of a study of epithelial cells with progenitor behavior that contribute to tissue repair as well as the mechanisms involved in mouse and human lung regeneration. In addition, we describe therapeutic strategies to promote or induce lung regeneration and the cell-based strategies tested in clinical trials for the treatment of IPF. Finally, we discuss the challenges, concerns and limitations of applying these therapies of cell transplantation in IPF patients. Further research is still required to develop successful strategies focused on cell-based therapies to promote lung regeneration to restore lung architecture and function.